Hence, modulation of intercellular redox homeostasis and downregulation of WT1 expression both are associated with differentiation of HL-60 leukemia cells, and SHK may be an agent for leukemia differentiation therapy under non-cytotoxic concentration. This evidence concerns the gene SHPK and leukemia.